Company intelligence / Profile preview

Reveal Biosciences

San Diego, California, United Statesbiopharmatrend.com ↗

Ownership: Private
Employees: ~18
Development stage: Commercial

Overview

Reveal Biosciences developed proprietary computational pathology platforms that combine traditional histopathology with artificial intelligence to deliver actionable data for research, diagnostics, and clinical labs. Their technologies improve accuracy and efficiency in tissue sample analysis for pharmaceutical, biotech, academic, and government clients. The company was acquired by CellCarta in May 2021.

Modalities: Immunohistochemistry (IHC)In situ hybridization (ISH)Immunofluorescence (IF)Histopathology
Industry: Pathology

Beyond the preview

Go deeper on Reveal Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Reveal Biosciences.

Explore the full profile